Metric Finance
LearnFAQ
LearnFAQ

Learn / QURE

NASDAQ: QURE

uniQure N.V. (QURE) stock, explained like you're 5

uniQure N.V. trades on the Nasdaq under the ticker QURE. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.6 billion dollars.

Ticker
QURE
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.6 billion dollars

Is uniQure N.V. a small, medium or large cap company?

No. uniQure N.V. is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.6 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How uniQure N.V. makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves QURE stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • QURE Jumps 20% Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 (Stocktwits)
  • uniQure (NasdaqGS:QURE) Stock Forecast & Analyst Predictions (Simply Wall Street)
  • QURE Nov 2026 44.000 call (QURE261120C00044000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • JPMorgan Chase reports a passive stake in uniQure (QURE) through four subsidiaries. (Stock Titan)
  • uniQure: The Market Graded The Wrong Exam (NASDAQ:QURE) (Seeking Alpha)

Follow QURE in your daily brief

Each trading day at 5 PM ET we post what happened to uniQure N.V. and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow QURE

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about uniQure N.V. stock

What does uniQure N.V. do?

uniQure N.V. trades on the Nasdaq under the ticker QURE. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.6 billion dollars.

What is the ticker symbol for uniQure N.V.?

uniQure N.V. trades under the ticker QURE on the Nasdaq.

What is uniQure N.V.'s market cap?

uniQure N.V. is a small cap stock with a market cap of about 1.6 billion dollars.

How does uniQure N.V. make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves QURE stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow QURE stock every day?

Add QURE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow QURE daily

A free brief on uniQure N.V. and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare QURE: QURE vs NVS, QURE vs AZN, QURE vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed